Clinical Trial Update: SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

View source ↗

Summary

The SYTHROM cohort trial in myeloproliferative neoplasms with thrombotic complications has completed, evaluating the impact of cytoreductive therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloproliferative Neoplasms

Snippet

Sponsor: Nantes University Hospital | Conditions: Thrombotic Patients, Diagnosis of Myeloproliferative Neoplasia | Status: COMPLETED